In this week’s edition of InnovationRx, we look at the boom in autoimmune disease therapies, OpenAI’s healthcare push, Vertex’s $10 billion purchase of Crinetics, and more. To get it in your inbox, subscribe here.
AbbVie’s Skyrizi is on track to become the world’s second-highest selling…
Leave a Reply